Systemic sclerosis and localized scleroderma in childhood.
Juvenile scleroderma syndromes, including the systemic and the localized varieties, represent the third most frequent chronic rheumatic conditions in pediatric rheumatology practice. In children, systemic sclerosis shows a significantly less frequent involvement of all organs, a higher prevalence of arthritis and myositis, and a better outcome than in adults. Recently, new classification criteria were proposed, which help improve patient care by enabling earlier, more definite diagnoses and by standardizing the conduct of clinical trials. Localized scleroderma is the more frequent subtype of scleroderma in childhood. It comprises a group of distinct conditions that involve mainly the skin and subcutaneous tissues. They range from small plaques of fibrosis involving only the skin to diseases causing significant functional deformity with various extracutaneous features.
Zulian
Francesco
F
Department of Pediatrics, Pediatric Rheumatology Unit, University of Padova, Via Giustiniani 3, 35128 Padova, Italy. zulian@pediatria.unipd.it
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010789:Phototherapy / Q000379:methods; D012594:Scleroderma, Localized / Q000188:drug therapy / Q000503:physiopathology; D012595:Scleroderma, Systemic / Q000188:drug therapy / Q000503:physiopathology
D007166:Immunosuppressive Agents